WASATCH ADVISORS LP – Esperion Therapeutics, Inc. Transaction History
WASATCH ADVISORS LP portfolio value:
$50.00M
portfolio value
WASATCH ADVISORS LP quarter portfolio value change:
+5.35%
quarter
Esperion Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -1.10% | -82.99K shares | 2.00M | $6.7 | 7.46M |
| Q2 2022 | share | Decrease | -7.38% | -601.37K shares | 10.18M | $6.36 | 7.54M |
| Q1 2022 | share | Increase | +27.58% | 1.76M shares | 5.87M | $4.64 | 8.14M |
| Q4 2021 | share | Increase | +95.04% | 3.11M shares | -7.52M | $4.96 | 6.38M |
| Q3 2021 | share | Decrease | -13.08% | -492.57K shares | -40.21M | $12.05 | 3.27M |
| Q2 2021 | share | Decrease | -8.53% | -351.15K shares | -35.84M | $21.15 | 3.76M |
| Q1 2021 | share | Increase | +3.00% | 120.07K shares | 11.56M | $28.05 | 4.11M |
| Q4 2020 | share | Increase | +65.91% | 1.58M shares | 14.38M | $26 | 3.99M |
| Q3 2020 | share | Increase | +93.64% | 1.16M shares | 25.71M | $37.17 | 2.40M |
| Q2 2020 | share | Increase | +37.30% | 338.09K shares | 35.27M | $51.31 | 1.24M |
| Q1 2020 | share | Increase | +36.35% | 241.62K shares | -11.05M | $31.53 | 906.33K |
| Q4 2019 | share | Increase | +5.44% | 34.31K shares | 16.52M | $59.63 | 664.70K |
| Q3 2019 | share | Decrease | -1.25% | -7.97K shares | -6.58M | $36.66 | 630.39K |
| Q2 2019 | share | Increase | +0.09% | 586 shares | 4.09M | $46.52 | 638.37K |
| Q1 2019 | share | Increase | +13.36% | 75.16K shares | -274K | $40.15 | 637.78K |
| Q4 2018 | share | Increase | +0.96% | 5.33K shares | 1.15M | $46 | 562.62K |
| Q3 2018 | share | Increase | +3.01% | 16.27K shares | 3.52M | $44.37 | 557.28K |
| Q2 2018 | share | Decrease | -8.50% | -50.23K shares | -21.56M | $39.19 | 541.01K |
| Q1 2018 | share | Decrease | -14.72% | -102.02K shares | -2.88M | $72.33 | 591.24K |
| Q4 2017 | share | Decrease | -2.82% | -20.13K shares | 9.88M | $65.84 | 693.26K |
| Q3 2017 | share | Decrease | -5.60% | -42.31K shares | 782K | $50.12 | 713.40K |
| Q2 2017 | share | Decrease | -1.41% | -10.82K shares | 7.90M | $46.28 | 755.71K |
| Q1 2017 | share | Increase | +42.43% | 228.34K shares | 20.32M | $35.31 | 766.54K |
| Q4 2016 | share | Increase | +2.18% | 11.47K shares | -557K | $12.52 | 538.19K |
| Q3 2016 | share | Decrease | -1.32% | -7.05K shares | 2.02M | $13.85 | 526.71K |
| Q2 2016 | share | Decrease | -29.69% | -225.40K shares | -7.24M | $9.88 | 533.77K |
| Q1 2016 | share | Increase | +6.09% | 43.60K shares | -3.41M | $16.91 | 759.18K |